NCT03065699 - Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 9, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

January 15, 2020

Conditions

Acute on Chronic Liver Failure

Interventions

DEVICE

DIALIVE Liver Dialysis Device

ACLF patients will receive dialysis treatment for 8-12 hrs/day and on three to five consecutive days over a 10-day time period. Dialysis treatment is performed by using the DIALIVE device provided by YAQRIT Ltd.

Trial Locations (12)

18051

University Hospital of Rostock, Rostock

94800

Paul Brousse Hospital, Villejuif

Unknown

university Hospital Graz, Graz

University Hospital Erasmus, Brussels

University Hospital, Aarhus

Hôpital Beaujon, Clichy

Fundeni Clinical Institute, Bucharest

Hospital Clinic Barcelona, Barcelona

University Hospital Gregorio Maragnon, Madrid

university hospital BASILDON, Basildon

NW3 2QG

Royal Free Hospital London NHS, London

NG7 2UH

Queens Medical Centre, Nottingham

All Listed Sponsors

collaborator

European Foundation for Chronic Liver Failure

UNKNOWN

collaborator

University College, London

OTHER

collaborator

Fakkel bvba

INDUSTRY

lead

Yaqrit Ltd

INDUSTRY